COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 3 FDA records to the applicant name Gyrus Acmi, Inc.. The collection includes 1 510(k) clearance. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 2, 2026 to Aug 20, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NJK appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P180007, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 6675 185th Ave. NE, Redmond, WA, 98052. Recorded on P180007/S016, decision dated Aug 20, 2026.
Device categories in this collection
Valve, Pulmonary; Electrosurgical, Cutting & Coagulation & Accessories.
Changes described in PMA records
FDA’s recorded scope: Approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P180007.
Aug 20, 2026 · Normal 180 Day Track No User FeeFDA’s recorded scope: The firm is submitting this 30-Day Notice of a change in the verification and validation process of the Water Treatment System. The firm is adding endotoxin testing for the water samples and related process modifications to the manufacturing work instruction.
May 7, 2026 · 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.